Table 3 Protein expression of DR4, DR5, BIRC5/Survivin, cIAP1 and cIAP2 by immunohistochemistry.
Tumor samples | PROTEIN EXPRESSION OF DR4, DR5, cIAP1, cIAP2 and BIRC5/Survivin BY IMMUNOHISTOCHEMISTRY | |||||||
|---|---|---|---|---|---|---|---|---|
DR4 | DR5 | cIAP1 | cIAP2 | BIRC5/Survivin | KRAS mutation status | Differentiation | TNM | |
T24 | +++ | +++ | + | + | ++ | KRAS mutant | Middle-low | T3N2M1 |
T108 | +++ | ++ | + | + | ++ | KRAS mutant | N/A | T3N0M0 |
T113 | ++ | ++ | + | + | +++ | KRAS wild type | Middle | T2N1M0 |
T114 | + | + | − | − | + | KRAS mutant | N/A | N/A |
T118 | ++ | + | − | + | + | KRAS wild type | Middle | T3N2M0 |
T121 | ++ | + | − | − | + | KRAS mutant | N/A | N/A |
T127 | ++ | + | + | + | ++ | KRAS mutant | Middle | T1N1M0 |
T131 | ++/+++ | ++/+++ | + | + | ++ | KRAS wild type | Middle | T2N1M0 |
T132 | +++ | ++ | + | + | ++ | KRAS mutant | Middle | T2N1M1 |
T139 | +++ | +++ | + | + | ++ | KRAS wild type | Middle | T3N0M0 |
T140 | + | +/++ | − | − | +/− | KRAS mutant | N/A | N/A |
T145 | +++ | ++ | + | + | ++ | KRAS mutant | Middle | T3N1M0 |
T151 | +++ | +++ | + | + | +++ | KRAS mutant | Middle | T3N1M0 |
T166 | +++ | ++ | +/− | − | ++ | KRAS wild type | Low | T2N0M0 |
T167 | +++ | +++ | + | + | ++ | KRAS wild type | Middle | T3N1M1 |
T178 | +++ | +++ | + | + | ++ | KRAS wild type | Middle | T3N1M0 |
T182 | +++ | ++ | + | + | ++ | KRAS wild type | Low | T3N0M0 |
T185 | ++ | ++ | − | + | ++ | KRAS mutant | Middle | T3N2M1 |
T189 | +++ | +++ | +/− | + | +++ | KRAS mutant | Low | T3N1M0 |
T193 | +++ | +++ | + | + | ++ | KRAS mutant | Middle | T3N2M0 |
T194 | ++ | + | +/− | + | + | KRAS mutant | Middle | T3N0M0 |
T196 | +++ | +++ | + | + | +++ | KRAS mutant | Middle | T3N1M0 |
T197 | +++ | ++ | − | + | +++ | KRAS mutant | Low | T3N0M0 |
T200 | ++ | ++ | − | + | + | KRAS mutant | Middle | T3N0M0 |
T201 | ++ | + | +/− | + | + | KRAS mutant | Middle | T3N2M1 |
